https://www.theguardian.com/us-news/2023/jun/10/lecanemab-leqembi-alzheimers-drug-fda-advisers
Panel’s opinion could pave way for full regulatory approval next month for treatment of disease that affects 6.5m Americans
Create an account or login to join the discussion